Bioventure Partners

Bioventure is a UAE-based biopharmaceutical company focused on the licensing, registration, and commercialization of biosimilars and innovative therapeutics across the Middle East and Africa (MEA). As a subsidiary of GlobalOne Healthcare Holding (and recently acquired by KELIX bio), the company serves as the exclusive strategic partner for Alvotech's biosimilar portfolio in the region, including the approved adalimumab biosimilar Simlandi. Bioventure's business model integrates tech transfer, local manufacturing through its specialized subsidiaries, and a robust pipeline of biologics targeting autoimmune disorders, oncology, and ophthalmology. The company plays a pivotal role in expanding access to affordable, high-quality medicines in emerging markets through strategic global partnerships.